A chronicle of the 17-alpha hydroxyprogesterone caproate story to prevent recurrent preterm birth

Medicine & Life Sciences

• 17 alpha-Hydroxyprogesterone Caproate 100%
• Premature Birth 62%
• Drug Approval 20%
• United States Food and Drug Administration 16%
• Medicine 15%
• Placebos 7%
• Infant Death 7%
• Mothers 6%
• Confidence Intervals 6%
• Birth Rate 6%
• North America 5%
• Advisory Committees 5%
• Formal Social Control 5%
• Canada 4%
• Obstetrics 4%
• Health Care Costs 4%
• Nervous System 4%
• Observational Studies 4%
• Public Health 3%
• Physicians 3%
• Delivery of Health Care 3%
• Pregnancy 3%
• Child 2%
• Pharmaceutical Preparations 2%
• Therapeutics 1%